Erratum to MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8

Erratum to: Transl Cancer Res 2020;9:3507-17

In the May 2020 issue of Translational Cancer Research, the article “MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8” authored by Shen et al. (1), was published with some errors in Figure 5. Figure 5 should be corrected as below and the figure legend remains intact.

Figure 5 The effects of miR-106a overexpression on migration and invasion in the transwell culture system. The migration function of PC-3 (A) and DU145 (B) (compared to Ad-con) cells was significantly inhibited after miR-106a overexpression. The invasion capability of PC-3 (C) and DU145 (D) (compared to Ad-con) cells was significantly restrained following miR-106a overexpression. Cells were stained by methylrosanilinium chloride solution. The bar within the picture. A single asterisk indicates P<0.05. Double asterisks indicate P<0.001.

The sentence in the “Results” section “Notably, miR-106a overexpression abrogated cell migration at 8, 12 and 24 h post-transfection (Figure 5A,B).” should be corrected to “Notably, miR-106a overexpression abrogated cell migration at 8, 16 and 24 h post-transfection (Figure 5A,B)”.

The authors apologize for this error, and state that it does not affect the scientific conclusions of the article.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Shen P, Sun G, Zhao P, et al. MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8. Transl Cancer Res 2020;9:3507-17. [Crossref] [PubMed]